Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
UNH

UnitedHealth

$178.36

2.77 (1.58%)

, MRK

Merck

$64.77

-0.165 (-0.25%)

14:37
05/25/17
05/25
14:37
05/25/17
14:37
Hot Stocks
Optum, Merck collaborate to advance value-based reimbursement models »

Optum, the health…

UNH

UnitedHealth

$178.36

2.77 (1.58%)

MRK

Merck

$64.77

-0.165 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

BMY

Bristol-Myers

$53.97

0.15 (0.28%)

, LLY

Eli Lilly

$78.00

0.04 (0.05%)

10:39
05/25/17
05/25
10:39
05/25/17
10:39
Periodicals
FDA chief urges regulations to ease generic drug entry to market, WSJ says »

Dr. Scott Gottlieb, the…

BMY

Bristol-Myers

$53.97

0.15 (0.28%)

LLY

Eli Lilly

$78.00

0.04 (0.05%)

JNJ

Johnson & Johnson

$126.80

0.13 (0.10%)

MRK

Merck

$64.77

-0.16 (-0.25%)

PFE

Pfizer

$32.01

-0.045 (-0.14%)

MYL

Mylan

$39.18

-0.41 (-1.04%)

CELG

Celgene

$117.75

0.44 (0.38%)

ABBV

AbbVie

$65.98

0.05 (0.08%)

AMGN

Amgen

$154.60

0.53 (0.34%)

VRX

Valeant

$13.06

0.13 (1.01%)

AGN

Allergan

$224.81

0.65 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 26

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 09

    Jun

  • 09

    Jun

  • 09

    Jun

  • 14

    Jun

  • 14

    Jun

  • 22

    Jun

  • 19

    Jul

  • 14

    Aug

  • 24

    Aug

  • 27

    Aug

  • 03

    Sep

  • 22

    Sep

  • 09

    Oct

ADAP

Adaptimmune

$5.32

-0.02 (-0.37%)

, MRK

Merck

$64.93

0.38 (0.59%)

08:09
05/25/17
05/25
08:09
05/25/17
08:09
Hot Stocks
Adaptimmune initiates NY-ESO SPEAR T-cells study with Keytruda »

Adaptimmune Therapeutics…

ADAP

Adaptimmune

$5.32

-0.02 (-0.37%)

MRK

Merck

$64.93

0.38 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.93

0.38 (0.59%)

08:02
05/25/17
05/25
08:02
05/25/17
08:02
Hot Stocks
Merck enters worldwide license agreement with Teijin for antibody candidate »

Merck announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

Wednesday
BMY

Bristol-Myers

$53.80

-0.41 (-0.76%)

11:16
05/24/17
05/24
11:16
05/24/17
11:16
Hot Stocks
Bristol-Myers says FDA accepts sBLA to extend use of Opdivo »

Bristol-Myers Squibb …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

Tuesday
MRK

Merck

$64.55

0.51 (0.80%)

16:38
05/23/17
05/23
16:38
05/23/17
16:38
Hot Stocks
Merck says FDA approves new indication for KEYTRUDA »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.55

0.505 (0.79%)

15:08
05/23/17
05/23
15:08
05/23/17
15:08
Hot Stocks
FDA grants accelerated approval to Merck cancer treatment based on biomarker »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

LOXO

Loxo Oncology

$46.35

0.21 (0.46%)

, RXDX

Ignyta

$6.80

-0.1 (-1.45%)

15:04
05/23/17
05/23
15:04
05/23/17
15:04
Periodicals
Loxo Oncology, Ignyta 'following Merck regulatory path,' Feuerstein says »

Adam Feuerstein of…

LOXO

Loxo Oncology

$46.35

0.21 (0.46%)

RXDX

Ignyta

$6.80

-0.1 (-1.45%)

MRK

Merck

$64.48

0.44 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 09

    Jun

  • 13

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.04

0.26 (0.41%)

06:56
05/23/17
05/23
06:56
05/23/17
06:56
Hot Stocks
FDA grants priority review to Merck's sBLA for KEYTRUDA »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

Monday
MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.